parKLIMson organiseert een internationaal mini-symposium over klimmen met Parkinson.
1. Het programma
18:00u. Klimmen voor deelnemers aan het symposium
19:00u. Demonstratie parKLIMson
19.00u. Intro parKLIMson – Ton van den Berg
20:00u. Start lezing
20.00u. Status onderzoek naar Parkinson en Bewegen - Bas Bloem
20.30u. Status onderzoek naar Parkinson en Klimmen - Heidemarie Zach
21.00u. Praktijk van Parkinson en Klimmen - Molly Cupka
21.30u. Interactive discussie over Parkinson en Klimmen - Molly Cupka, Heidemarie Zach, Bas Bloem, Ton van den Berg
2. Registreren:
volgt later
3. Voorstellen sprekers
About Molly Cupka
Molly Cupka is the founder and Executive Director of Up Ending Parkinson’s. She launched the organization in 2012 after recognizing the potential of climbing to improve the lives of people with Parkinson’s. Under her leadership, UEP has grown from a single climbing group into a nationwide community with over 84 locations dedicated to helping people with Parkinson’s remain active and connected. Molly also served as a researcher on a study examining the effects of rock climbing for people with Parkinson’s. The research was published in Archives of Physiotherapy in 2024.
About Up Ending Parkinson's
Up ENDing Parkinson's is a national nonprofit that empowers people living with Parkinson’s disease through guided rock climbing. In partnership with climbing gyms and trained volunteers across the country, UEP creates supportive opportunities for participants to build strength, balance, confidence, and meaningful community.
Ap Prof.PD.Dr.med.univ. Heidemarie Zach, PHD, Bsc.
Education
• Medical Degree (Human Medicine), Medical University of Vienna
• Degree in Sports Science, University of Vienna
• Specialist Training in Neurology, Department of Neurology, Medical University of Vienna / Vienna General Hospital (AKH Wien)
• PhD in Neuroscience, Radboud University, Nijmegen, the Netherlands
• Postgraduate Diploma in Medical Hypnosis, Medical University of Vienna
Teaching
• Long-standing Tutor and Teaching Assistant, Department of Anatomy, Medical University of Vienna
• Tutor, Department of Physiology, Medical University of Vienna
• Lecturer in the Pharmaceutical Representative Training Programme, WIFI Vienna
• Lecturer in the Medical Curriculum, Medical University of Vienna
• Lecturer at the Centre for Sports Science and University Sports, University of Vienna
• Deputy Scientific Director of the Postgraduate Programme in Medical Hypnosis, Medical University of Vienna
Clinical Practice
• Clinical experience in the Botulinum Toxin Clinic since the beginning of specialist training in Neurology
• Movement Disorders Clinic, Department of Neurology, Medical University of Vienna, with a focus on Parkinson’s disease
Research Interests
• Non-pharmacological treatment approaches in Parkinson’s disease and the neurophysiological effects of physical activity and exercise
• “Climb Up, Head Up!” – a personal research focus investigating the effects of sport climbing in people with Parkinson’s disease
• Objective assessment of motor function, particularly gait and balance disorders
• Medical hypnosis
Professor Bas Bloem is a neurologist at the Radboud University Medical Centre, Nijmegen, The Netherlands. He received his medical degree, with honours, at Leiden University Medical Centre in 1993 and obtained his PhD degree in 1994. He trained as a neurologist between 1994 and 2000. He received additional training as specialist in movement disorders during fellowships at The Parkinson's Institute, Sunnyvale, California, and the Institute of Neurology, Queen Square, London. In September 2008, he was appointed professor of neurology, with movement disorders as special area of interest.
Professor Bloem is on the editorial board of leading national and international (scientific ) journals. Since 2020 he serves as Co-Editor in Chief of the Journal of Parkinson's Disease. In 2002, Professor Bloem founded the Radboudumc Center of Expertise for Parkinson's & Movement Disorders and, together with Dr. Marten Munneke, developed ParkinsonNet, an innovative care concept for Parkinson's patients consisting of 70 professional regional networks.
Professor Bloem has published over 850 publications, including more than 780 peer-reviewed international papers. This includes a series of large clinical trials, all of which were published in high-end scientific journals. He has also supervised 57 successfully completed PhD dissertations. His H-index is 89 (Web of Science) / 102 (Research Gate) / 117 (Google Scholar). In 2021, he was ranked among the top 1% of most cited scientists of the past 10 years (https://bit.ly/3QOFHEw).
Professor Bloem is attached to the following societies:
- Royal Holland Society of Sciences
- Academia Europaea
- Fellow of the Royal College of Physicians of Edinburgh
- Royal Netherlands Academy of Arts and Sciences
In 2018, he won the Tom Isaacs award in recognition of his long-standing achievements in the field of Parkinson's disease. In 2022 he received the Stevin Award, the highest recognition for a Dutch scientist who has had greatest impact on society.
Professor Bloem has two main research interests: cerebral compensatory mechanisms, especially in the field of gait and balance; and healthcare innovation, aiming to develop and scientifically evaluate patient-centred collaborative care. More recently, his work is also focusing on wearable sensors, machine learning and artificial intelligence. In his latest work, he also focuses on prevention of Parkinson’s disease, with emphasis on eradication of environmental toxins, and use of lifestyle interventions. Bloem also values the publication of remarkable observations in single patients.